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undetermined. This study aimed to determine the prevalence,
and any association between equine respiratory herpesviruses
EHV1, -2, -4 and -5 infection in horses with and without clinical
signs of respiratory disease. Cases were those horses that were
presented for exclusion of equine inﬂuenza virus (EIV) that
exhibited signs of respiratory disease including pyrexia, nasal
discharge, and/or coughing during the 2007 Australian EIV
outbreak. Nasal swabs were taken from 407 horses in Victoria,
which remained free of EIV and included clinically normal horses
that had been screened for regulatory purposes. Samples were
placed in viral transport media and subsequently stored at -80C.
Quantitative PCR was performed using primers speciﬁc for EHV1,
-4, -2 and -5. A multiplex Taqman assay was performed with
labelled probes for the alphaherpesviruses EHV-1 and -4. Sepa-
rate individual assays for the gammaherpesviruses EHV-2 and -5
were also performed. Of the three horses detected shedding EHV-
1, and the ﬁve shedding EHV-4 only onewas noted to have clinical
signs referable to respiratory disease. The proportion of EHV5
infected horses in the diseased group (85/120, 70.8%) was
signiﬁcantly greater than those not showing signs of disease (137/
249, 55%). The odds of EHV-5 positive horses demonstrating
clinical signs of respiratory disease were twice that of EHV-5
negative horses (OR 1.99, 95% CI 1.25 to 3.16). Horses infectedwith
EHV-2 made up a smaller proportion in the diseased group (18/
120, 15.0%) compared to those without disease (61/249,
24.5%,P¼0.042). The odds of disease in EHV-2 positive horses
were approximately half that in EHV-2 negative horses (OR 0.54,
95%CI 0.31 to 0.97) Fifty of the 83 horses (60.2%) shedding EHV-2
were also shedding EHV5, however there was no greater likeli-
hood of EHV5 detection in these horses compared to those
without detectable EHV-2 (199/324, 61.4%; P¼0.90). The dual
infected horses were nomore likely to exhibit signs of disease (14/
46, 30.4%) than those shedding EHV-2 alone (4/33, 12.1%;
P¼0.063) or EHV-5 alone (71/176, 40.3%; P¼0.24). Logistic
regression showed no interaction between EHV-2 and -5 shed-
ding on clinical signs of respiratory disease (P¼0.41). No quanti-
tative difference between mean loads of EHV shedding between
diseased and non-diseased horses was able to be detected. The
clinical signiﬁcance of respiratory gammaherpesvirus infections
in horses remains to be determined, however this survey adds to
the mounting body of evidence associating EHV5 with equine
respiratory disease.Acknowledgements
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Belgium, ZAVENTEM, BelgiumHorses are usually infected during the ﬁrst months of life by
several equine herpesviruses, such as EHV-1, EHV-4 or EHV-2. The
persistence of these respiratory viruses through establishment of
latency, often characterised by an absence of clinical signs, rep-
resents a real risk to the horse population. Reactivation of latent
EHV could cause disease in both carriers and naive animals in
contact. A better understanding of the immune response to EHV
infection is necessary to improve our methods of prevention and
decrease the risk of transmission. The objectives of this study
were 1/ to characterise the cytokine gene expression proﬁle of
PBMC after in vitro EHV infection (EHV-1, EHV-4 and EHV-2) and
2/ To determine the efﬁcacy of the inactivated Parapoxvirus ovis
(iPPVO), a known immunomodulator in horses , against these
same viruses. PBMC were isolated from 3 horses and infected in
vitro with EHV-1, EHV-4 or EHV-2, in the presence or absence of
iPPVO. In vitro culture of PBMC with EHV-1, EHV-4, EHV-2 and
iPPVO induced a signiﬁcant increase of IFN-a, IFN-b and IFN-g
gene expression. Moreover, EHV-2 induced a signiﬁcant increase
of IL-1b, IL-6 and TNF-amRNA. The presence of iPPVO induced an
earlier and stronger expression of IFN-a, IFN-b and IFN-g during
EHV infection. The presence of iPPVO reduced also the inﬂam-
matory response induced by EHV-2. In conclusion, this study
suggests that the presence of iPPVO potentiates the development
of the immune response during infection EHV in vitro.
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In virology, different conventional methods are commonly used
for virus titration and infectivity studies. Most of them are based
on direct examination of viral cytopathic effect, which is time
consuming, tedious and requires an endpoint reading. The RTCA
xCELLigence system (ACEA Biosciences) has been developed to
follow cellular events and their dynamics in real time using a
micro-electrical biosensor technology. The aim of this study was
to evaluate the feasibility of using this biosensor technology to
measure the effect of different equid herpesviruses on equine
dermal cell cultures, with or without antiviral acyclovir treat-
ment. Cells were infected with EHV-1 (VR700), EHV-4 (VR2230),
EHV-2 (VR701) or EHV-3 (VR352). The viral effects were moni-
tored by 3 different methods: impedance measurements (RTCA),
cytopathic effects recording (microscopy) and viral load quanti-
ﬁcation (qPCR). The RTCA technology showed a dose dependent
drop of the cellular index induced by speciﬁc impedance varia-
tions measured during growth of each virus tested. These results
correlated with the cytopathic effect induced by the different
herpesvirus species, as well as viral loads measured by qPCR. For
example, after 3 days of incubation with EHV-1, RTCA results
showed an increase of the cellular index from 0% (infection
10th IEIDC Abstracts / Journal of Equine Veterinary Science 39 (2016) S66eS71S70without antiviral) to 45% and 100% in presence of Acyclovir (10ml/
mL and 100 mg/mL, respectively). These results are correlated
with the decreased of viral load measured in the presence of
Acyclovir: 1010 genome copies/mLwith EHV-1 only,106 copies/mL
with EHV-1 + Acyclovir 10 mg/mL and 105 copies/mLwith EHV-1 +
Acyclovir 100 mg/ mL. In conclusion, the cellular impedance
monitoring system is a new real-time method to monitor cell
growth and viral proliferation in cell cultures. This technology is
well adapted for high-throughput screening of antiviral mole-
cules. In fact, the xCELLigence system enables continuous
impedance measurement and quantiﬁcation of cell adhesion,
proliferation, cell death and detachment during viral infection.
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Equine gamma herpesvirus type 5 (EHV-5) is related to the hu-
man Epstein eBarr virus (EBV) and has frequently been observed
in equine populations worldwide. EHV-5 was previously assumed
to be low to nonpathogenic, however, studies have also related
the virus to the severe lung disease equine multinodular pul-
monary ﬁbrosis (EMPF). Genetic information of EHV-5 is scanty,
where the whole genomewas recently described and only limited
nucleotide sequences are available. In this study, partial of the
EHV-5 glycoprotein B (gB) gene were analyzed in nine horses by
using next generation sequencing (NGS). The included samples
were from eight healthy Standardbred trotters at the same pro-
fessional training yard that were sampled twice with one year
apart, and from one horse diagnosed with EMPF from which
samples were taken pre and post mortem. The analysis resulted in
obtaining of 27 partial gB gene sequences, 11 unique sequence
types and 5 amino acid sequences. These sequences could be
classiﬁed within four genotypes (I-IV) of EHV-5 gB gene based on
the degree of similarity of the nucleotide and amino acid se-
quences, and in this work horses were shown to be identiﬁed
with up to three different genotypes at the same time. The ob-
servations showed a range of interactions between EHV-5 and the
host over time, where the same virus persists in some horses
whereas others have a more dynamic infection pattern including
strains from different genotypes. This study provides insight into
genetic variation and dynamic of EHV-5 and highlights that
further work is needed to understand the EHV-5 interaction with
its host.Poster
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Infections caused by equine Gammaherpesvirus 2 and 5 usually
occur during the early stages of the life of horses, followed by
periodic reactivation of a latent infection. The occurrence of
equine herpesvirus 2 (EHV-2) is related with immunosup-
pression and has been associated with outbreaks of respiratory
disease. Alternatively, equine herpesvirus 5 (EHV-5) has
tropism for the respiratory tract and has been related to equine
multinodular pulmonary ﬁbrosis. Since the presence of these
viruses was never reported in Brazil, the aim of this study was
to detect EHV-2 and -5 in Brazilian horses. Twenty-six nasal
swabs were collected from horses without signs of respiratory
distress from two distinct pure-breed farms (A, n¼18; B, n¼8).
Nucleic acid puriﬁcation was performed by using a combination
of the phenol/chloroform/isoamyl alcohol and silica/guanidi-
nium isothiocyanate methods. The identiﬁcation of EHV-2 and
-5 was done by using a nested PCR assay that targeted the gB
gene. The PCR results were conﬁrmed by sequencing using ABI
3500 Genetic Analyzer. From Farm A, 5 nasal swabs were
positive for EHV-2, 10 contained EHV-5 DNA, and one sample
had the DNA of both viruses. From the second farm, 7 samples
were positive for EHV-2, 6 for EHV- 5, and 6 contained the DNA
of both viruses. In summary, from a total of 26 nasal swabs,
46.1% (12) were contained EHV-2 DNA, 61.5% (16) were positive
for EHV-5, and 26.9% (7) had the DNA of both viruses. This was
the ﬁrst detection of equine gammaherpesviruses 2 and 5 in
horses from Brazil. These results obtained from asymptomatic
horses suggest that these viruses are probably endemic in
Brazil, similarly as previously reported in Europe, USA and
Australia.
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Recombination allows evolution to occur in viruses that have an
otherwise stable DNA genome with a low rate of nucleotide
substitution. High-throughput sequencing of complete her-
pesviral genomes has recently allowed ﬁeld recombination to
